Search research articles
Contact Us
Filters
Showing results (71-80 of 95) with videos related to
Page
of 10
Sort By:
Blood Cancer Journal
|
January 3, 2026
Elevated non-clonal bone marrow plasma cell fraction at diagnosis is associated with improved outcomes in multiple myeloma
Saurabh Zanwar, Dragan Jevremovic, Prashant Kapoor, et al.
JCO Oncology Practice
|
April 15, 2025
Outpatient Management of Bispecific Related Toxicities: An Observational Study of Safety Outcomes and Resource Utilization
Jenna R Puttkammer, Jason N Barreto, Chelsee J Jensen, et al.
American Journal of Hematology
|
June 26, 2026
Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple Myeloma
Kenneth J C Lim, Shaji Kumar, Ricardo Parrondo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 24, 2023
Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML
Christopher T Letson, Maria E Balasis, Hannah Newman, et al.
American Journal of Hematology
|
January 11, 2022
Multicentric Castleman disease: A single center experience of treatment with a focus on autologous stem cell transplantation
Nadine H Abdallah, Thomas Habermann, Francis K Buadi, et al.
Blood Cancer Journal
|
February 18, 2025
Clonal plasma cell proportion in the synthetic phase identifies a unique high-risk cohort in multiple myeloma
Saurabh Zanwar, Dragan Jevremovic, Prashant Kapoor, et al.
Blood
|
October 26, 2021
Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformation
Xiaona You, Fabao Liu, Moritz Binder, et al.
Blood Cancer Journal
|
June 14, 2018
Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria
Arjun Lakshman, S Vincent Rajkumar, Francis K Buadi, et al.
Blood Advances
|
April 10, 2026
Diagnosis and management of immune effector cell-associated enterocolitis (IEC-EC) following ciltacabtagene autoleucel
Kenneth Jc Lim, Hee Eun Lee, Zongming Eric Chen, et al.
JACC. Cardiooncology
|
April 22, 2026
Cardiac Biomarker Complete Response in AL Amyloidosis: Characteristics, Cardiac Recovery, and Survival of 63 Patients
Eli Muchtar, Susan Geyer, Angela Dispenzieri, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 95) with videos related to
Sort By:
Page
of 10
Blood Cancer Journal
|
January 3, 2026
Elevated non-clonal bone marrow plasma cell fraction at diagnosis is associated with improved outcomes in multiple myeloma
Saurabh Zanwar, Dragan Jevremovic, Prashant Kapoor, et al.
JCO Oncology Practice
|
April 15, 2025
Outpatient Management of Bispecific Related Toxicities: An Observational Study of Safety Outcomes and Resource Utilization
Jenna R Puttkammer, Jason N Barreto, Chelsee J Jensen, et al.
American Journal of Hematology
|
June 26, 2026
Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple Myeloma
Kenneth J C Lim, Shaji Kumar, Ricardo Parrondo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 24, 2023
Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML
Christopher T Letson, Maria E Balasis, Hannah Newman, et al.
American Journal of Hematology
|
January 11, 2022
Multicentric Castleman disease: A single center experience of treatment with a focus on autologous stem cell transplantation
Nadine H Abdallah, Thomas Habermann, Francis K Buadi, et al.
Blood Cancer Journal
|
February 18, 2025
Clonal plasma cell proportion in the synthetic phase identifies a unique high-risk cohort in multiple myeloma
Saurabh Zanwar, Dragan Jevremovic, Prashant Kapoor, et al.
Blood
|
October 26, 2021
Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformation
Xiaona You, Fabao Liu, Moritz Binder, et al.
Blood Cancer Journal
|
June 14, 2018
Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria
Arjun Lakshman, S Vincent Rajkumar, Francis K Buadi, et al.
Blood Advances
|
April 10, 2026
Diagnosis and management of immune effector cell-associated enterocolitis (IEC-EC) following ciltacabtagene autoleucel
Kenneth Jc Lim, Hee Eun Lee, Zongming Eric Chen, et al.
JACC. Cardiooncology
|
April 22, 2026
Cardiac Biomarker Complete Response in AL Amyloidosis: Characteristics, Cardiac Recovery, and Survival of 63 Patients
Eli Muchtar, Susan Geyer, Angela Dispenzieri, et al.
Page
of 10